Eye-Link Wisconsin
  • Application
  • Donate
  • Resources
  • News
  • Contact
  • Application
  • Donate
  • Resources
  • News
  • Contact

New gene and drug therapies for dimming eyes!

5/22/2019

 
Retinitis Pigmentosa, commonly referred to as RP, is one of the leading causes of blindness in the United States. There are over two hundred forms of RP. The National Institute of Health sponsors research involved in drug or gene therapies designed to reduce the “noise” which is often clutter or the pigmenting of good retinal cells. The “noise” seems to be generated by nerve cells in the retina reducing vision. The therapies work by repairing or limiting the “noise” generated by these nerve cells.

UC Berkeley neurobiologists have already shown that this approach improves vision in mice with RP that would slowly leave them Blind.

The work at Berkeley is funded by the National Eye Institute, and the Thome and Fighting Blindness.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    December 2022
    June 2022
    March 2022
    November 2021
    March 2020
    December 2019
    May 2019
    February 2019
    January 2019

    Categories

    All

    RSS Feed

CONTACT US

Mail donations to:
Eye-Link Wisconsin
P.O. Box 845
Green Bay, WI 54305

SEND APPLICATIONS TO:

Eye-Link Wisconsin
Attn: Jeffrey J. Scott
201 North Walbridge Avenue
Unit 116
Madison, WI 53714

BOARD OF DIRECTORS

Jeff Agee-Aguayo
Baylee Alger

Gabriel DeLeon
Deborah Hoeft
Jeffrey Scott
Sheng Vue

For questions regarding your application: Jeffrey Scott (608) 692-6358
© 2020 Eye-Link Foundation. All Rights Reserved.